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SUMMARY
Somalia has suffered from a civil war during the last 10 years. In this period the use of whole
blood has increased at least twofold in Mogadishu, Somalia compared with pre-war. Screening
possibilities are limited. Recent data concerning the prevalence of infections with blood-borne
and sexually transmitted agents are not available from this country. To investigate the spread
of human immunodeficiency virus (HIV-1}2) and other blood-borne or sexually transmitted
agents we tested a total of 256 serum samples collected in the summer of 1995 from blood
donors, hospitalized children and adults in Mogadishu. The hepatitis B surface antigen
(HbsAg) carrier rate was 19–1%, 5–6% and 21–3% among blood donors, hospitalized children
and hospitalized adults, respectively. However, no children under 2 years of age were
HbsAg positive. The overall presence of antibodies against hepatitis C virus (HCV) was 2–4%
(6}256). In blood donors this was 0–6% (1}157). In none of the samples tested, antibodies
against HIV 1 and 2 or human T-cell lymphotropic viruses (HTLV I and II) were detected.
Our results indicate that, during the civil war in Somalia, no evidence of an increase of HIV
infections was found. Our findings indicate that preventive measures in Somalia should focus
mainly on prevention of HBV-infections. HBV-vaccine could be administered within the
framework of the expanded programme on immunization, as none of the children less than 2
years of age were HbsAg positive.
INTRODUCTION
Only limited population-based surveys to establish the
prevalence of serum antibodies against blood-borne
and sexually transmitted agents have been carried out
in sub-Saharan African countries. However, some
studies carried out among the general population and
at risk groups indicate that Central and Eastern
Africa have been amongst the most severely affected
regions in the world in this respect [1–4]. In Somalia
infection with hepatitis B virus (HBV) is widespread
and also infections with hepatitis C virus (HCV) have
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been identified [5]. Few data are available about the
prevalence of HIV infections and no data exist on
infections with Chlamydia trachomatis and herpes
simplex virus type 2 (HSV-2). In contrast, data from
the neighbouring countries, such as Kenya, Djibouti
and Ethiopia indicate that the seroprevalence of HIV
specific antibodies varies from 5–15% in both their
blood donors and general populations [6–8]. The
limited data reported from Somalia, involving both
rural and urban populations, did not show the
presence of antibodies against HIV in serum samples
collected between 1978 and 1984, between July 1986
and January 1987 and between February and March
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1989 [9–11]. The last serological survey, dating back
to 1990, was conducted among 155 prostitutes in
Mogadishu. Only one sample was HIV positive [12].
In a follow up study carried out in 1991 the
seroprevalence of HIV-1 antibodies was 3% amongst
prostitutes in Mogadishu [13]. No subsequent studies
were carried out due to the civil war and to the
collapse of the health infrastructure in Somalia. The
first four cases of acquired immunodeficiency syn-
drome (AIDS) were officially reported from Somalia
in July 1989, a number that had increased to 13 by
December 1991 [14, 15]. These figures are clearly far
below those reported from the neighbouring countries.
To further investigate the spread of HIV and other
bloodborne or sexually transmitted agents, we carried
out a serological study amongst individuals selected
randomly from a population of blood donors,
hospitalized adults and children in Mogadishu,
Somalia.
We screened all sera for antibodies to HIV-1 and
HIV-2, hepatitis C virus (HCV), human T-cell
leukaemia virus types 1 and 2 (HTLV-I, HTLV-II),
herpes simplex type 2 (HSV-2), Chlamydia trachomatis
and Treponema pallidum, as well as for hepatitis B
virus (HBV) markers.
MATERIALS AND METHODS
Site of the study and serum samples
The Benadir Emergency Hospital in Mogadishu,
Somalia is a government hospital of 144 beds, in
which approximately 50–100 children are seen each
day in the adjoining outpatient clinic. This hospital is
the main hospital in Mogadishu, serving a population
of about 1–5 million. During the study period the
hospital was mainly dealing with war casualties.
Between 21 and 31 July 1995, blood donors donating
blood to their relatives (family donors), acutely ill
adults and children admitted to two hospitals, were
included in the study. At the time of collection of
serum samples the living conditions in Mogadishu
were poor and the health infrastructure which had
collapsed due to the ongoing war was being partially
restructured.
Blood donors
During the sampling period, 273 healthy adults
donated blood to their relatives, requiring surgery.
For 157 of those donors (57–5%) adequate serum
samples were available and all consented to participate
in the study. All were young male adults except one
female. Their age range was 18–40 years, with a mean
age of 26 years.
Hospitalized adults
Fifty-seven serum samples were collected from adults
admitted to the Benadir hospital for tuberculosis
(nfl 18), malaria or malaria-like illness (nfl 19),
acute respiratory infections (nfl 12) and unknown
diagnosis (nfl 8). No clinically evident case of
hepatitis was seen among the patients. The age range
of these patients was 17–66 years.
Hospitalized children
Forty-two serum samples were collected from hos-
pitalized children, ranging in age from 5 months to 9
years. These patients were initially seen and sampled
at the outpatient clinic of Benadir hospital, and
hospitalised at the SOS paediatric hospital in Moga-
dishu (about 15 km apart). They were admitted for
measles, tuberculosis, anaemia and other febrile
illnesses.
The serum samples of the respective donors and
patients were stored during the collection period at
4 °C, until shipment to the University Hospital
Rotterdam where the samples were stored at fi20 °C
before they were tested. All the sera were tested for
antibodies against HIV-1 and 2, HTLV I and II and
HCV. For the detection of the respective HBV
markers, limited number of samples were available ;
115 serum samples from blood donors, 36 samples
from hospitalized children and 47 samples from
hospitalized adults. In addition we tested 54 serum
samples from blood donors for the presence of HSV-
2, Chlamydia trachomatis and Treponema pallidum
specific IgG antibodies.
Laboratory analysis
For the detection of the respective IgG antibodies and
HBV antigen commercially available assays were
used. HIV-1 and HIV-2 specific IgG antibodies were
tested using a recombinant specific enzyme-linked
immunosorbent assay (EIA) (Biotest AG, Dreieich,
Germany). HTLV I and II antibodies were measured
using the Vironostica EIA (Organon Technika,
Boxtel, Netherlands). Detection of HCV specific
antibodies was carried out using an HCV EIA
system (Ortho Diagnostic Systems, Neckargemu$ nd,
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Table 1. Prealence of serum antibodies to HIV, HCV and HTLV in
selected Somalian groups (percentage)
Anti-HIV Anti-HCV Anti-HTLV
Groups No. tested No. pos. % No. pos. % No. pos. %
Blood donors 157 0 0 1 0–6 0 0
Hosp. children 42 0 0 1 2–4 0 0
Hosp. adults 57 0 0 4 7–0 0 0
Total 256 0 0 6 2–0 0 0
Table 2. Prealence of HBV markers in selected Somalian groups
(percentage)
HbsAg aHbs aHbs›aHbc
Groups No. tested No. pos. % No. pos. % No. pos. %
Blood donors 115 22 19–1 18 15–6 33 28–7
Hosp. children
! 1 year 15 0 0–0 3 20–0 0 0–0
1–2 years 15 0 0–0 3 20–0 0 0–0
" 2 years 6 2 33–3 1 16–7 0 0–0
Hosp. adults 47 10 21–3 2 4–3 14 29–8
Total 198 34 17–2 27 13–6 47 23–7
Germany). If a serum sample was considered positive
for HCV by EIA, this was confirmed by HCV
immunoblot (Chiron, Emeryville, USA). HCV con-
firmed positive serum samples were further typed by
PCR as described [16]. For the detection of HBV
specific markers, samples were tested for the presence
of antibodies against Hbc and Hbs and the presence
of HbsAg (DiaSorin, Vercelli, Italy). Antibodies
against HSV-2 and Tp were measured with the
CAPTIA Select HSV-2 EIA and CAPTIA Select
Syph-G (Centocor, Malvern, USA). Ct specific IgG
antibodies were detected using a peptide specific EIA
system (Labsystems, Helsinki, Finland). Ninety-five
percent confidence intervals (CI) were calculated for
the observed percentages.
RESULTS
A total of 256 serum samples from blood donors and
hospitalized patients were tested for the presence of
antibodies against HIV-1 and 2, HTLV-I and HTLV-
II (Table 1). In none of the 256 serum samples were
antibodies to HIV-1 and 2, HTLV-I and HTLV-II
detected. Six out of 256 (2–3%, CI 0–5–4–2) were
seropositive for HCV, after confirmation by immuno-
blot. Among the blood donors, antibodies against
HCV were detected in only 1 out of 157 (0–6% CI,
0–1–9) serum samples, in 1 out of 42 hospitalized
children (2–4%, CI 0–7–0) and in 4 of 57 hospitalized
adults (7–0%, CI 0–4–13–6). All of the six HCV positive
sera were tested for HCV-RNA by RT-PCR. One of
the six samples could be classified by subsequent
sequence analysis of the 5 UTR, as HCV type 1B. In
34 of the 198 tested serum samples (17–2%, CI
11–9–22–4) from the blood donors and hospitalized
patients HbsAg was detected (Table 2). Among the
blood donors, HbsAg, anti-Hbs and anti-Hbc com-
bined with anti-Hbs was detected in 22}115 (19–1%),
in 18}115 (15–6%) and in 33}115 (28–7%) respectively.
In the samples of the hospitalized children and adult
patients, HbsAg, anti-Hbs and anti-Hbc combined
with anti-Hbs was detected in 2}36 (5–6%), 7}36
(19–4%), and in 0}36, and in 10}47 (21–3%), in 2}47
(4–3%) and in 14}47 (29–8%) respectively. HBV
markers in the hospitalized children, stratified by age,
are shown in Table 2. HbsAg was found in none of 30
children younger than 2 years of age. In those children
over 2 years of age, 2 out of 6 samples tested positive.
Antibodies to Hbs were detected in 3 out of 15
children (20%) less than 1 year of age, in 3 of 15
children between 1 and 2 years (20%) and 1 out of 6
(16–7%) of those above 2 years of age. If anti-Hbc was
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combined with anti-Hbs no children in any age group
had antibodies to anti-Hbc and anti-Hbs combined
(Table 2).
A total of 54 serum samples from the blood donors
were tested for the presence of specific antibodies
against HSV-2, Treponema pallidum and Chlamydia
trachomatis. Specific antibodies against HSV-2,
Treponema pallidum and Chlamydia trachomatis were
demonstrated in 2}54 (3–7%), 1}54 (1–9%) and in
12}54 (22–2%) respectively.
DISCUSSION
Knowledge about the distribution of sexually trans-
mitted diseases in different parts of the world and in
particular in Africa is important for the planning of
preventive measures and development of vaccination
[17]. The present study, which under the current
situation in Somalia was difficult to carry out, failed
to detect any HIV infections amongst the groups
studied. Earlier studies have also shown that HIV-
infection is not widespread in Somalia [9–12]. This
study also indicates that HBV, as well as HCV are
common infections after the age of 2 years in all age
groups of Somalians. However the prevalence of both
infections compare favourably to those found in other
sub-Saharan African countries [2]. The low prevalence
rate of HIV infections in Somalia is somehow
surprising as HIV and HBV share their major modes
of transmission. These findings contrast sharply with
those recently observed in Eritrean prostitutes, in
whom high rates of HIV-1 antibodies (29%) and
relatively low HbsAg (3%) positivity were found
[18]. In our study none of the 256 individuals tested
positive for HIV antibodies, while a high percentage
of individuals were positive for HBV markers. The
first documented cases of AIDS in Somalia coincided
with the beginning of the collapse of the health infra-
structure due to civil war. This observation as well as
the lack of systematic serologic surveillance and
proper hospital documentation of AIDS cases in the
whole country may have masked the real incidence of
HIV-infection in Somalia as a whole. Nevertheless as
HIV infection is apparently not yet widespread in
Somalia and the possibilities for its transmission are
abundantly present, especially in the present situation
of civil unrest, design and implementation of primary
intervention strategies are of utmost importance.
These should primarily be targeted at education of
sexually active people, proper serological surveillance
programmes and the screening of donated blood.
In Africa the numerous cases of severe anaemia
caused by malaria, malnutrition and infectious dis-
eases, has created a large requirement for transfusion
of whole blood. At present most of the blood collected
in Somalia is used for war causalities and for young
children before they reach the age of five years when
most of them are still uninfected with HBV. Therefore
these children are at increased risk to acquire
transfusion related HBV and other bloodborne infec-
tions. It should however be borne in mind that the best
and most feasible approach to reduce HBV infection
in Somalia is probably the implementation of HBV
vaccination in the framework of the ongoing EPI
programme of WHO [19]. In the present study we
demonstrated that none of the children aged up to 2
years of age were found positive for HbsAg, which
further confirms the relatively limited perinatal trans-
mission of HBV infection in Africa [20]. The present
study also shows that in Mogadishu there is a risk of
0–6% of being infected with HCV through blood
transfusion in previously uninfected recipients. Only a
limited number of sera from male donors could be
examined for specific antibodies against HSV,
Treponema pallidum and Chlamydia trachomatis. As
compared to one other Somalian study [21],
Treponema pallidum antibody positivity was low in
our population (1–9 versus 24%, respectively). This
difference may be due to the different social back-
grounds of the study populations.
We conclude that the systematic screening of blood
donated in Somalia is crucial to prevent, or at least
minimize transmission of blood-borne agents. Taken
together our data indicate that the prevalence of
bloodborne and sexually transmitted agents, with the
exception of HBV is relatively limited in Somalia at
present. However since all these agents share certain
routes of transmission, the design and implementation
of blood screening procedures as well as intervention
strategies to prevent sexual transmission, should be
given priority.
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